L2R ALERT
Pediatric Vaccine ApprovalAges 5 and up can now get protection from COVID-19!
The FDA and CDC have authorized the Pfizer-BioNTech COVID-19 vaccine for emergency use to prevent COVID-19 in children ages 5 to 11.
Children aged 5 to 11 account for almost 40% of all pediatric COVID-19 cases, close to the highest case rate for any age group. Although children are less likely to become seriously ill due to an infection, hospitalization and mortality rates have increased among this population as the highly transmissible delta variant has driven infections in all age groups.
Between August and early October, COVID-19 outbreaks have closed 272 school districts throughout the US, affecting…
2,000+ schools
1 million+ students
68,000+ teachers
These outbreaks and school closings disproportionately impacted children of color.
What is Emergency Use Authorization?
Help drive vaccine uptake in this age group by hosting a school-based vaccination event for your district with L2R! Contact us today or visit our school-based vaccination event page to learn more.
What we know
We know that the vaccine is the best protection available and want to be sure all children can be served.
School-based vaccination events…
Help minimize lost learning days
Offer vaccinations to students and families from a trusted community institution
Help level the playing field for vaccine access
Drive vaccine uptake in the wider community
RESOURCES
Menu of Tests
A quick guide to available L2R testing options
Testing FAQs
Answering key questions about L2R testing strategies for parents, guardians and families
Vaccine FAQS
Learn more about the vaccines & why you should get vaccinated
Vaccine & Testing FAQs
Learn why vaccines & testing are the dynamic duo that will help schools open and stay open this fall with confidence
School-Based Vax Events
Washington schools can take the lead in supporting vaccine uptake in communities by hosting vaccination events during the 2021 school year!